Cargando…
Engineered collagen-binding serum albumin as a drug conjugate carrier for cancer therapy
Serum albumin (SA) is used as a carrier to deliver cytotoxic agents to tumors via passive targeting. To further improve SA’s tumor targeting capacity, we sought to develop an approach to retain SA-drug conjugates within tumors through a combination of passive and active targeting. SA was recombinant...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Association for the Advancement of Science
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693903/ https://www.ncbi.nlm.nih.gov/pubmed/31453327 http://dx.doi.org/10.1126/sciadv.aaw6081 |